📰 Alpha Da News
Page 3 - Alpha Da News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Alpha Da. Real-time updates on events, politics, business and more.
November 28, 2023
- Interim data read-out of the first five treated patients demonstrated successful delivery in all five cases, as well as no product-related Serious Adverse Events - - First five patients received...
November 28, 2023
- Interim data read-out of the first five treated patients demonstrated successful delivery in all five cases, as well as no product-related Serious Adverse Events -
November 21, 2023
Alpha Tau Medical (NASDAQ:DRTS – Free Report) had its target price reduced by Piper Sandler from $12.00 to $8.00 in a research report released on Friday morning, Benzinga reports. Piper Sandler currently has an overweight rating on the stock. A number of other research analysts have also recently weighed in on the stock. HC Wainwright […]
November 13, 2023
Atalaya Capital Management LP grew its position in Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Free Report) by 256.3% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 280,474 shares of the company’s stock after purchasing an additional 201,755 shares during the period. Atalaya Capital Management LP’s […]
November 12, 2023
Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Free Report) was the target of a significant growth in short interest in the month of October. As of October 31st, there was short interest totalling 10,000 shares, a growth of 56.3% from the October 15th total of 6,400 shares. Based on an average trading volume of 9,800 […]
November 1, 2023
Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Free Report) saw a large growth in short interest in the month of October. As of October 15th, there was short interest totalling 6,400 shares, a growth of 8.5% from the September 30th total of 5,900 shares. Based on an average daily volume of 9,200 shares, the days-to-cover […]
October 30, 2023
JERUSALEM, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ:DRTS, DRTSW)), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™,
September 17, 2023
Alpha Tau Medical Ltd. (NASDAQ:DRTS – Get Free Report) was the recipient of a significant growth in short interest during the month of August. As of August 31st, there was short interest totalling 158,500 shares, a growth of 96.2% from the August 15th total of 80,800 shares. Based on an average daily volume of 70,900 […]
September 2, 2023
HC Wainwright reaffirmed their buy rating on shares of Alpha Tau Medical (NASDAQ:DRTS – Free Report) in a report published on Tuesday, Benzinga reports. The brokerage currently has a $9.00 price objective on the stock. HC Wainwright also issued estimates for Alpha Tau Medical’s Q3 2023 earnings at ($0.11) EPS, Q4 2023 earnings at ($0.11) […]
August 30, 2023
Alpha Tau Medical (NASDAQ:DRTS – Get Free Report) announced its quarterly earnings results on Monday. The company reported ($0.13) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.13), MarketWatch Earnings reports. Alpha Tau Medical Price Performance Shares of DRTS opened at $3.35 on Wednesday. The business’s 50 day moving average is […]